Godavari Drugs informs about disclosures
Godavari Drugs has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrimal.
The above information is a part of company’s filings submitted to BSE.
